John M Kelly

25PUBLICATIONS
105CO-AUTHORS
Molecular medicineBiologically active moleculesChemotherapyCardiology (incl. cardiovascular diseases)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Sep 09, 2026
IID432, a parasite-selective topoisomerase II inhibitor, achieves rapid single-dose parasite clearance in a murine chronic Chagas model.

|Jun 17, 2026
Synthesis and Evaluation of Nitroheterocyclic Aromatic Adamantanohydrazones with Trypanocidal Activity. Part III.

|Aug 05, 2025
Cryo-EM led analysis of open and closed conformations of Chagas vaccine candidate TcPOP.

Sagar Batra, Francisco Olmo, Timothy J Ragan

|Jul 09, 2025
Antitrypanosomal quinazolines targeting lysyl-tRNA synthetase show partial efficacy in a mouse model of acute Chagas disease.

Lindsay B Tulloch, Hugh Tawell, Annie E Taylor

|May 08, 2025
New Trypanosoma brucei acting derivatives incorporating 1-(4-phenyl)adamantane and 1-(4-phenoxyphenyl)adamantane.

Konstantina Stavropoulou, Angeliki Kaimaki, Maria Nikolaou

|May 07, 2025
Statins do not reduce the parasite burden during experimental Trypanosoma cruzi infection.

Sarah Razzaq, Francisco Olmo, Suresh B Lakshminarayana

Pageof 5

Frequent Collaborators

8 joint publications

Martin Craig Taylor

7 joint publications

Francisco A F

4 joint publications

Francisco Olmo

3 joint publications

Pascal Mäser